SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending on news of its central role in the UK's Maritime Nuclear Consortium, aiming to pioneer nuclear-powered shipping solutions with its SMR technology. This strategic move, alongside robust performance in civil aerospace and defense contracts, is generating strong community optimism and driving positive analyst sentiment.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst widespread discussions surrounding its namesake's recent assertive statements concerning Greenland and potential tariffs on European nations. The community is deeply divided, debating the geopolitical ramifications and potential market impacts, with many expressing frustration over the pervasive political commentary overshadowing fundamental stock analysis.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending as an anticipated Arctic blast and polar vortex are expected to bring extreme cold across much of the U.S., driving up heating demand. The community is actively debating the potential for a massive short squeeze and significant price surge, while others caution about the instrument's historical volatility.

V2X, Inc. provides solutions and support to defense clients globally. It delivers integrated solutions across the operations and logistics, aerospace, training and technology markets to national security, defense, civilian and international clients. The company was founded in February 2014 and is headquartered in Reston, VA.

V2X Inc

V2X Inc. is trending due to a series of significant new defense contract wins, including its operational role at the strategically important Pituffik Space Force base and involvement in the Golden Dome project, alongside the deployment of its advanced Tempest counter-UAS system. The community is buzzing with optimism, highlighting V2X's expanding market opportunity and appreciating its position as an undervalued defense prime contractor experiencing robust contract momentum as a major shareholder's overhang lessens.

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Pacira BioSciences Inc

Pacira BioSciences is trending significantly upward following a favorable patent litigation settlement for its flagship product, EXPAREL, effectively delaying substantial generic competition into the next decade. This resolution is instilling renewed investor confidence and positive analyst sentiment, as it addresses a major overhang for the non-opioid pain management company.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

CytomX Therapeutics Inc

CytomX Therapeutics is capturing significant market attention in anticipation of its Q1 2026 data readout for Varseta-M (CX-2051) in metastatic colorectal cancer, alongside recent strategic corporate developments. The community is actively discussing the drug's potential as a blockbuster, drawing comparisons to past successful ADC acquisitions and noting substantial institutional accumulation. This optimism persists despite recent price volatility as investors focus on the company's differentiated PROBODY platform addressing a critical unmet medical need.

Galaxy Digital Holdings Ltd.

Galaxy Digital (GLXY.TSX) is a focal point of intense community excitement, with its upcoming Nasdaq uplisting and significant CoreWeave deals for AI/HPC data centers fueling bullish sentiment. Investors are keenly anticipating a major repricing and increased institutional capital, positioning the company as a pivotal player in the evolving digital asset and AI infrastructure landscape, though some discussions note caution around potential volatility.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is experiencing a surge in trend due to community discussions highlighting consistent upward price movement and recent market cap growth, with speculation around a potential catalyst in early February. While proponents anticipate further gains, there's active debate and concern among users regarding price discrepancies on various platforms and whether the asset could be a "rug pull" or a scam.

Pony.ai, Inc. develops artificial intelligence-based robot designed for autonomous driving. The firm's software algorithms and infrastructure enables a vehicle to perceive its surroundings, predict what others will do, and maneuver itself accordingly. The company was founded by Jun Peng and Tian Cheng Lou in November 4, 2016 and is headquartered in Guangzhou, China.

Pony AI Inc. - ADR

Pony AI Inc

Pony AI is trending due to a flurry of positive developments, including achieving unit economics breakeven for its Gen-7 robotaxis and securing new partnerships for global fleet expansion in Europe, Singapore, and Qatar. This aggressive growth strategy and strong institutional backing, highlighted by bullish analyst ratings and investment plans from major mobility players, are fueling community discussions about the company's competitive advantage in the rapidly evolving autonomous vehicle sector. Investors are closely monitoring its trajectory in the global robotaxi race and anticipating future catalysts.

WELL Health Technologies Corp

WELL Health Technologies is generating significant discussion driven by its planned WELLSTAR spin-off and ongoing divestment of US assets, building on a track record of strong revenue growth and recent analyst target upgrades. While some long-term investors express frustration over past price volatility and perceived short-seller influence, a strong contingent within the community sees the stock as significantly undervalued, presenting a compelling buying opportunity amid its strategic corporate developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sumitomo Mitsui Trust Group Inc. Trims Holdings in Adaptive Biotechnologies Corporation $ADPT

Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 15.1% during the 3rd quarter, according to its most recent 13F...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CFO Sells $77,220.00 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CFO Kyle Piskel sold 4,290 shares of Adaptive Biotechnologies stock in a transaction that occurred on Monday, January 12th. The...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 79,590 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Francis Lo sold 79,590 shares of Adaptive Biotechnologies stock in a transaction that occurred on Monday, January 12th...

Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026

Adaptive Biotechnologies (NASDAQ:ADPT) used a presentation at the J.P. Morgan healthcare conference to outline growth drivers for its clonoSEQ minimal residual disease (MRD) franchise and to describe...

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - Still a Buy?

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - Time to Buy...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Francis Lo Sells 3,125 Shares

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Francis Lo sold 3,125 shares of the business's stock in a transaction that occurred on Friday, January 2nd. The shares...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Francis Lo Sells 4,394 Shares

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Francis Lo sold 4,394 shares of the stock in a transaction dated Monday, December 22nd. The shares were sold at an average...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 4,394 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Francis Lo sold 4,394 shares of the firm's stock in a transaction dated Monday, December 22nd. The stock was sold at an...

Voya Investment Management LLC Sells 255,297 Shares of Adaptive Biotechnologies Corporation $ADPT

Voya Investment Management LLC decreased its stake in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 16.4% in the third quarter, according to the company in its most...

Nikko Asset Management Americas Inc. Trims Stock Position in Adaptive Biotechnologies Corporation $ADPT

Nikko Asset Management Americas Inc. trimmed its holdings in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 29.3% during the 2nd quarter, according to the company in its most...

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

ADPT
Adaptive Biotechnologies Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADPT News

ADPTAdaptive Biotechnologies Corp